| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |